Your search history is turned on.
Date: February 1, 2024 Jurisdictions: British Columbia
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, DONALD GORDON, CHIEF FINANCIAL OFFICER OF 1325966 B.C. LTD., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of 1325966 B.C. LTD. (the issuer) for the interim period ended November 30, 2023 ...
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, DONALD GORDON, CHIEF EXECUTIVE OFFICER OF 1325966 B.C. LTD., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of 1325966 B.C. LTD. (the issuer) for the interim period ended November 30, 2023 ...
Micrologix Biotech Inc 1325966 B.C. LTD. Managements Discussion & Analysis Page 1 of 6 This managements discussion and analysis (MD&A) is provided to enable the reader to assess material changes in financial condition and results of operations of 1325966 B.C. LTD.(BC...
1325966 B.C. LTD. Condensed Interim Financial Statements For the Six Months Ended November 30, 2023 and 2022 (Unaudited) (Expressed in Canadian dollars) NOTICE OF NO AUDITOR REVIEW OF CONDENSED INTERIM FINANCIAL STATEMENTS Under National Instrument 51-102, continuous disclos...
Date: November 14, 2023 Jurisdictions: British Columbia
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, DONALD GORDON, CHIEF FINANCIAL OFFICER OF 1325966 B.C. LTD., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of 1325966 B.C. LTD. (the issuer) for the interim period ended August 31, 2023 ...
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, BRIAN PETERSON, CHIEF EXECUTIVE OFFICER OF 1325966 B.C. LTD., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of 1325966 B.C. LTD. (the issuer) for the interim period ended August 31, 2023 ...
_ 1 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Donald Gordon , CFO of 1325966 B.C. LTD., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by ref...
_ 1 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Brian Peterson , CEO of 1325966 B.C. LTD., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by re...
Micrologix Biotech Inc 1325966 B.C. LTD. Managements Discussion & Analysis Page 1 of 6 This managements discussion and analysis (MD&A) is provided to enable the reader to assess material changes in financial condition and results of operations of 1325966 ...